Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Telomir Pharmaceuticals Says Telomir-1 Shuts Down Cellular Energy Pathways, Mitochondrial Function In Aggressive Breast Cancer Cells; Plans To Expand Studies To Pancreatic, Leukemia Models, Conduct Further Animal Studies For IND Submission

Author: Benzinga Newsdesk | October 08, 2025 03:11pm

Posted In: TELO